Pluri, Inc. (PLUR)
2.25
-0.01
(-0.44%)
USD |
NASDAQ |
Jun 11, 16:00
2.25
0.00 (0.00%)
After-Hours: 19:57
Pluri Gross Profit Margin (Quarterly) : -43.11% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -43.11% |
| December 31, 2025 | -21.72% |
| September 30, 2025 | -4.75% |
| June 30, 2025 | 24.12% |
| March 31, 2025 | 14.99% |
| December 31, 2024 | 23.24% |
| September 30, 2024 | 41.41% |
| June 30, 2024 | 32.29% |
| March 31, 2024 | 14.08% |
| December 31, 2023 | 39.05% |
| September 30, 2023 | -24.07% |
| June 30, 2023 | 22.52% |
| March 31, 2023 | -1.15% |
| December 31, 2022 | -4.75K% |
| September 30, 2022 | -14.94% |
| June 30, 2022 | |
| March 31, 2022 | -7.26% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | -1.58K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -900.0% |
| September 30, 2018 | -12.48K% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -920.0% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 77.07% |
| September 30, 2015 | -426.3% |
| June 30, 2015 | -516.0% |
| March 31, 2015 | -425.3% |
| December 31, 2014 | -434.7% |
| September 30, 2014 | -427.4% |
| June 30, 2014 | -419.1% |
| March 31, 2014 | -407.4% |
| December 31, 2013 | -404.2% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | 16.18% |
| Evogene Ltd. | 0.60% |
| Scinai Immunotherapeutics Ltd. | -228.6% |
| BioLineRx Ltd. | 61.64% |
| Kamada Ltd. | 42.25% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -80.96% |
| Return on Invested Capital | -96.57% |
| Profit Margin (Quarterly) | -3.70K% |
| Operating Margin (Quarterly) | -3.91K% |
| Return on Net Operating Assets | -198.8% |